Mousumi Mandal

Dr. Mousumi Mandal

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
MMMd Abdullah Al Mamun
Md Abdullah Al Mamun
Ahmed RakibAhmed Rakib
Ahmed Rakib
MMMousumi Mandal
Mousumi Mandal
USUdai Singh
Udai Singh
Over the last few decades, the prevalence of metabolic diseases such as obesity, diabetes, non-alcoholic fatty liver disease, hypertension, and hyperuricemia has surged, primarily due to high-fat diet (HFD). The pathologies of these metabolic diseases show disease-specific alterations in the composition and function of their gut microbiome. How HFD alters the microbiome and its metabolite to mediate adipose tissue (AT) inflammation and obesity is not well known. Thus, this study aimed to identify the changes in the gut microbiome and metabolomic signatures induced by an HFD to alter obesity. To explore the changes in the gut microbiota and metabolites, 16S rRNA gene amplicon sequencing and metabolomic analyses were performed after HFD and normal diet (ND) feeding. We noticed that, at taxonomic levels, the number of operational taxonomic units (OTUs), along with the Chao and Shannon indexes, significantly shifted in HFD-fed mice compared to those fed a ND. Similarly, at the phylum level, an increase in Firmicutes and a decrease in Bacteroidetes were noticed in HFD-fed mice. At the genus level, an increase in Lactobacillus and Ruminococcus was observed, while Allobaculum, Clostridium, and Akkermansia were markedly reduced in the HFD group. Many bacteria from the Ruminococcus genus impair bile acid metabolism and restrict weight loss. Firmicutes are efficient in breaking down complex carbohydrates into short-chain fatty acids (SCFAs) and other metabolites, whereas Bacteroidetes are involved in a more balanced or efficient energy extraction. Thus, an increase in Firmicutes over Bacteroidetes enhances the absorption of more calories from food, which may contribute to obesity. Taken together, the altered gut microbiota and metabolites trigger AT inflammation, which contributes to metabolic dysregulation and disease progression. Thus, this study highlights the potential of the gut microbiome in the development of therapeutic strategies for obesity and related metabolic disorders.

14 February 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
MMMd Abdullah Al Mamun
Md Abdullah Al Mamun
Ahmed RakibAhmed Rakib
Ahmed Rakib
MMMousumi Mandal
Mousumi Mandal
Santosh KumarSantosh Kumar
Santosh Kumar
BSBhupesh Singla
Bhupesh Singla
USUdai Singh
Udai Singh
Polyphenols, long-used components of medicinal plants, have drawn great interest in recent years as potential therapeutic agents because of their safety, efficacy, and wide range of biological effects. Approximately 75% of the world’s population still use plant-based medicinal compounds, indicating the ongoing significance of phytochemicals for human health. This study emphasizes the growing body of research investigating the anti-adipogenic and anti-obesity functions of polyphenols. The functions of polyphenols, including phenylpropanoids, flavonoids, terpenoids, alkaloids, glycosides, and phenolic acids, are distinct due to changes in chemical diversity and structural characteristics. This review methodically investigates the mechanisms by which naturally occurring polyphenols mediate obesity and metabolic function in immunomodulation. To this end, hormonal control of hunger has the potential to inhibit pro-obesity enzymes such as pancreatic lipase, the promotion of energy expenditure, and the modulation of adipocytokine production. Specifically, polyphenols affect insulin, a hormone that is essential for regulating blood sugar, and they also play a role, in part, in a complex web of factors that affect the progression of obesity. This review also explores the immunomodulatory properties of polyphenols, providing insight into their ability to improve immune function and the effects of polyphenols on gut health, improving the number of commensal bacteria, cytokine production suppression, and immune cell mediation, including natural killer cells and macrophages. Taken together, continuous studies are required to understand the prudent and precise mechanisms underlying polyphenols’ therapeutic potential in obesity and immunomodulation. In the interim, this review emphasizes a holistic approach to health and promotes the consumption of a wide range of foods and drinks high in polyphenols. This review lays the groundwork for future developments, indicating that the components of polyphenols and their derivatives may provide the answer to urgent worldwide health issues. This compilation of the body of knowledge paves the way for future discoveries in the global treatment of pressing health concerns in obesity and metabolic diseases.

1 January 2016 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
MMMousumi Mandal
Mousumi Mandal
BGBiswajoy Ghosh
Biswajoy Ghosh
AAAnji Anura
Anji Anura
PMPabitra Mitra
Pabitra Mitra
TPTanmaya Pathak
Tanmaya Pathak
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee
Mathematical modeling of plasticity expressed in EMT undergoing HaCaT cell population endorsed with molecular expressions and phenotype morphometry.

1 August 2020 in Materialia
Verified
Journal Article
Closed access
MRMonika Rajput
Monika Rajput
MMMousumi Mandal
Mousumi Mandal
AAAnji Anura
Anji Anura
AMAnurup Mukhopadhyay
Anurup Mukhopadhyay
BSBhuvaneshwaran Subramanian
Bhuvaneshwaran Subramanian
JCJyotirmoy Chatterjee
Jyotirmoy Chatterjee

26 November 2016 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
BMBikash Mondal
Bikash Mondal
DMDhrubajyoti Maulik
Dhrubajyoti Maulik
MMMousumi Mandal
Mousumi Mandal
GSGautam Narayan Sarkar
Gautam Narayan Sarkar
SSSanjay Sengupta
Sanjay Sengupta
DGDebidas Ghosh
Debidas Ghosh

5 May 2025 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
Ahmed RakibAhmed Rakib
Ahmed Rakib
AMAbdullah Al Mamun
Abdullah Al Mamun
MMMousumi Mandal
Mousumi Mandal
PSPriti Sinha
Priti Sinha
USUdai Singh
Udai Singh
Now recognized as a global health crisis, obesity has been linked to an increased risk of many types of cancer, including those of the breast, colon, rectum, uterus, gallbladder, and ovary. Obesity and cancer share several characteristics at the cellular, molecular, and epigenetic levels. Obesity is characterized by chronic inflammation of the adipose tissue (AT), resulting in genotoxic stress that further induces metabolic complications and contributes to the initiation and progression of cancer. The excessive accumulation of AT provides adipokines and lipids to engage tumor cells with stromal and immune cells to infiltrate carcinomas and secrete a plethora of cytokines, chemokines, and growth factors within the tumor microenvironment (TME) that contribute to carcinogenesis. Obesity also alters the metabolic reprogramming of immune cells, including macrophages, neutrophils, and T cells, thereby providing a suitable environment for the growth and progression of cancer. Obesity-associated metabolic dysregulation also perturbs the gut microbiome, which produces metabolites that can further increase the risk of cancer progression. This review will discuss links between obesity and cancer progression, including several crucial pathways that bridge the crosstalk between obesity-associated changes in AT inflammation, immune cells, adipokines, chemokines, and tumor cells to support cancer progression. We will also discuss our insights into the mechanisms by which obesity-driven factors influence metabolic reprogramming and touch base on how obesity mediates microbiome dysbiosis to alter metabolite and affect cancer progression. Altogether, this review highlights the crossroads of the obesity–cancer axis, describes its salient features, and presents possible therapeutic approaches for obesity-related cancers.